Inclisiran Effectiveness in China: a Pragmatic Randomized Trial

Clinical trial NCT06941792 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06941792
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Heart Disease

Start date: 2025-06-17
Primary completion: 2027-04-30
Enrollment: 1590

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.